Home » Topics » BioWorld Science, Dermatologic

BioWorld Science, Dermatologic
RSS

Dapsone development for acne and burn itch progresses at Atrix

Oct. 16, 2001

Second phase I/II clinical trial of Levulan PDT begins for treatment of Barrett's esophagus

Oct. 11, 2001

FDA and EMEA accept Amevive filing for psoriasis

Oct. 11, 2001

Karo Bio updates KB-002611 clinical development

Oct. 10, 2001

New compounds designed at Welsh university inhibit retinoic acid metabolism

Oct. 5, 2001

Canadian trials of ISAtx-247 commence in psoriasis patients

Oct. 5, 2001

FDA approves Dermagraft living human dermal substitute

Oct. 4, 2001

Skin repair trial for sun damage set to begin with NV-07a

Oct. 2, 2001

Full enrollment reached in Vasogen psoriasis trial

Sep. 28, 2001

Potent new p38 MAP kinase inhibitor suppresses cytokine release, skin inflammation

Sep. 27, 2001

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 30, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 28, 2026
Chinese biotechs gain leverage as partners in dealmaking
BioWorld
China’s biotech ecosystem has crossed an inflection point, and Chinese biotechs are gaining leverage in dealmaking, executives from multinational companies said...
Bio Korea 2026 kicks off with spotlight on oligonucleotides
BioWorld
Three decades of trial-and-error, and the resulting safety data, in the oligonucleotide-based therapeutic space have paved way for the present-day innovations and...
Roche identifies new TREM2 agonists
BioWorld Science
F. Hoffmann-La Roche Ltd. and Hoffmann-La Roche Inc. have prepared and tested new compounds acting as triggering receptor expressed on myeloid cells 2 (TREM2)...